Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Nov;83(22):8492–8495. doi: 10.1073/pnas.83.22.8492

Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.

P Nambi, M Whitman, G Gessner, N Aiyar, S T Crooke
PMCID: PMC386956  PMID: 2430290

Abstract

Rat thoracic aortic smooth muscle cells (line A10, ATCC CRL 1476) display a high density of atrial natriuretic factor (ANF) receptors. ANF stimulated the accumulation of cGMP in these cells in a time- and dose-dependent fashion. These cells are known to display a high density of vasopressin receptors of the vascular V1 subtype. These vasopressin receptors mediate inhibition of isoproterenol-stimulated cAMP accumulation and stimulation of inositol phosphate accumulation and calcium fluxes. Addition of [8-arginine]vasopressin ([Arg8]VP) to these cells inhibited ANF-stimulated cGMP accumulation. Inhibition of cGMP accumulation was dependent on the concentration of [Arg8]VP, with half-maximal and maximal effects occurring at 0.4 and 10 nM, respectively. [Arg8]VP did not have significant effects on basal cGMP levels. The inhibition by [Arg8]VP appears to be mediated by V1 receptors, since the V2 renal receptor agonist [1-desaminocysteine,8-D-arginine]vasopressin was ineffective. Also, the selective V1 antagonist [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyltyrosine),8-arginine]vasopressin and the mixed V1/V2 antagonist [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl-D-tyrosine),4-valine,8-arginine]vasopressin blocked the [Arg8]VP-mediated effect, whereas the selective V2 antagonist [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-D-isoleucine,4-valine,8-arginine]vasopressin was minimally effective. These data show that in rat aortic smooth muscle cells, V1 receptors are negatively coupled to guanylate cyclase. These data also suggest that the vasoconstrictor activity of [Arg8]VP might involve inhibition of ANF-receptor-mediated vascular relaxation through inhibition of cGMP accumulation in addition to its effects on isoproterenol-mediated cAMP accumulation and inositol phosphate accumulation and calcium fluxes.

Full text

PDF
8492

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelstein R. S., Conti M. A., Hathaway D. R., Klee C. B. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase. J Biol Chem. 1978 Dec 10;253(23):8347–8350. [PubMed] [Google Scholar]
  2. Aiyar N., Nambi P., Stassen F. L., Crooke S. T. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci. 1986 Jul 7;39(1):37–45. doi: 10.1016/0024-3205(86)90435-2. [DOI] [PubMed] [Google Scholar]
  3. Butlen D., Guillon G., Rajerison R. M., Jard S., Sawyer W. H., Manning M. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol. 1978 Nov;14(6):1006–1017. [PubMed] [Google Scholar]
  4. Chimoskey J. E., Spielman W. S., Brandt M. A., Heidemann S. R. Cardiac atria of BIO 14.6 hamsters are deficient in natriuretic factor. Science. 1984 Feb 24;223(4638):820–822. doi: 10.1126/science.6538050. [DOI] [PubMed] [Google Scholar]
  5. Currie M. G., Geller D. M., Cole B. R., Siegel N. R., Fok K. F., Adams S. P., Eubanks S. R., Galluppi G. R., Needleman P. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science. 1984 Jan 6;223(4631):67–69. doi: 10.1126/science.6419347. [DOI] [PubMed] [Google Scholar]
  6. De Léan A., Gutkowska J., McNicoll N., Schiller P. W., Cantin M., Genest J. Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci. 1984 Dec 3;35(23):2311–2318. doi: 10.1016/0024-3205(84)90522-8. [DOI] [PubMed] [Google Scholar]
  7. De Léan A., Racz K., Gutkowska J., Nguyen T. T., Cantin M., Genest J. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology. 1984 Oct;115(4):1636–1638. doi: 10.1210/endo-115-4-1636. [DOI] [PubMed] [Google Scholar]
  8. Doyle V. M., Rüegg U. T. Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun. 1985 Aug 30;131(1):469–476. doi: 10.1016/0006-291x(85)91826-1. [DOI] [PubMed] [Google Scholar]
  9. Fiscus R. R., Rapoport R. M., Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(6):415–425. [PubMed] [Google Scholar]
  10. Fiscus R. R., Rapoport R. M., Waldman S. A., Murad F. Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochim Biophys Acta. 1985 Jul 30;846(1):179–184. doi: 10.1016/0167-4889(85)90124-7. [DOI] [PubMed] [Google Scholar]
  11. Geller D. M., Currie M. G., Wakitani K., Cole B. R., Adams S. P., Fok K. F., Siegel N. R., Eubanks S. R., Galluppi G. R., Needleman P. Atriopeptins: a family of potent biologically active peptides derived from mammalian atria. Biochem Biophys Res Commun. 1984 Apr 30;120(2):333–338. doi: 10.1016/0006-291x(84)91258-0. [DOI] [PubMed] [Google Scholar]
  12. Hirata Y., Tomita M., Yoshimi H., Ikeda M. Specific receptors for atrial natriuretic factor (ANF) in cultured vascular smooth muscle cells of rat aorta. Biochem Biophys Res Commun. 1984 Dec 14;125(2):562–568. doi: 10.1016/0006-291x(84)90576-x. [DOI] [PubMed] [Google Scholar]
  13. Kruszynski M., Lammek B., Manning M., Seto J., Haldar J., Sawyer W. H. [1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem. 1980 Apr;23(4):364–368. doi: 10.1021/jm00178a003. [DOI] [PubMed] [Google Scholar]
  14. Kuno T., Andresen J. W., Kamisaki Y., Waldman S. A., Chang L. Y., Saheki S., Leitman D. C., Nakane M., Murad F. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem. 1986 May 5;261(13):5817–5823. [PubMed] [Google Scholar]
  15. Lincoln T. M., Fisher-Simpson V. A comparison of the effects of forskolin and nitroprusside on cyclic nucleotides and relaxation in the rat aorta. Eur J Pharmacol. 1984 May 18;101(1-2):17–27. doi: 10.1016/0014-2999(84)90026-8. [DOI] [PubMed] [Google Scholar]
  16. Manning M., Klis W. A., Olma A., Seto J., Sawyer W. H. Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism. J Med Chem. 1982 Apr;25(4):414–419. doi: 10.1021/jm00346a016. [DOI] [PubMed] [Google Scholar]
  17. Manning M., Olma A., Klis W. A., Kolodziejczyk A. M., Seto J., Sawyer W. H. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin. J Med Chem. 1982 Jan;25(1):45–50. doi: 10.1021/jm00343a009. [DOI] [PubMed] [Google Scholar]
  18. Michell R. H., Kirk C. J., Billah M. M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans. 1979 Oct;7(5):861–865. doi: 10.1042/bst0070861. [DOI] [PubMed] [Google Scholar]
  19. Nambi P., Whitman M., Stassen F. L., Crooke S. T. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation. J Pharmacol Exp Ther. 1986 Apr;237(1):143–146. [PubMed] [Google Scholar]
  20. Napier M. A., Vandlen R. L., Albers-Schönberg G., Nutt R. F., Brady S., Lyle T., Winquist R., Faison E. P., Heinel L. A., Blaine E. H. Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5946–5950. doi: 10.1073/pnas.81.19.5946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oshima T., Currie M. G., Geller D. M., Needleman P. An atrial peptide is a potent renal vasodilator substance. Circ Res. 1984 May;54(5):612–616. doi: 10.1161/01.res.54.5.612. [DOI] [PubMed] [Google Scholar]
  22. Rapoport R. M., Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 1983 Mar;52(3):352–357. doi: 10.1161/01.res.52.3.352. [DOI] [PubMed] [Google Scholar]
  23. Sagnella G. A., MacGregor G. A. Physiology: cardiac peptides and the control of sodium excretion. Nature. 1984 Jun 21;309(5970):666–667. doi: 10.1038/309666a0. [DOI] [PubMed] [Google Scholar]
  24. Schenk D. B., Johnson L. K., Schwartz K., Sista H., Scarborough R. M., Lewicki J. A. Distinct atrial natriuretic factor receptor sites on cultured bovine aortic smooth muscle and endothelial cells. Biochem Biophys Res Commun. 1985 Mar 15;127(2):433–442. doi: 10.1016/s0006-291x(85)80179-0. [DOI] [PubMed] [Google Scholar]
  25. Silver P. J., Walus K., DiSalvo J. Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. J Pharmacol Exp Ther. 1984 Feb;228(2):342–347. [PubMed] [Google Scholar]
  26. Torphy T. J., Freese W. B., Rinard G. A., Brunton L. L., Mayer S. E. Cyclic nucleotide-dependent protein kinases in airway smooth muscle. J Biol Chem. 1982 Oct 10;257(19):11609–11616. [PubMed] [Google Scholar]
  27. Winquist R. J., Faison E. P., Nutt R. F. Vasodilator profile of synthetic atrial natriuretic factor. Eur J Pharmacol. 1984 Jun 15;102(1):169–173. doi: 10.1016/0014-2999(84)90353-4. [DOI] [PubMed] [Google Scholar]
  28. Winquist R. J., Faison E. P., Waldman S. A., Schwartz K., Murad F., Rapoport R. M. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7661–7664. doi: 10.1073/pnas.81.23.7661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES